Medicare Price Negotiation Should Not Exclude Acquisitions From R&D Spending, CMS Told

 
• By Cathy Kelly
  
Excluding acquisition costs from R&D spending could endanger the innovation ecosystem, stakeholders warned. (Shutterstock)

More from Medicare

More from Government Payers